Skip to main content

Table 2 CVD risk in disease free normal-weight and overweight subjects and in obese adults with CBPV abnormalities

From: Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults

 

Normal (n = 10)

Overweight (n = 10)

Obese (n = 8)

P**

WC (Women < 88 cm)*

71 ± 4

84 ± 6

109 ± 15

< 0.05

WC (Men < 102 cm)*

84 ± 7

97 ± 9

114 ± 6

< 0.05

SBP (< 120 mm Hg)*

113 ± 8

118 ± 10

129 ± 12

NS

DBP (< 80 mm Hg)*

72 ± 5

75 ± 5

80 ± 6

NS

FSG (< 100 mg/dL)*

89 ± 5

89 ± 8

102 ± 16

< 0.05

Total-C (< 200 mg/dL)*

181 ± 23

180 ± 20

223 ± 38

< 0.05

LDL-C (< 130 mg/dL)*

109 ± 25

96 ± 13

133 ± 34

< 0.05

HDL-C (> 50 mg/dL)*

63 ± 4

54 ± 16

46 ± 13

NS

TG (< 150 mg/dL)*

49 ± 12

112 ± 60

220 ± 111

< 0.05

Total-C/HDL-C ratio (< 5)*

2.9 ± 0.6

3.6 ± 0.9

5.2 ± 1.9

NS

LDL-C/HDL-C ratio (< 3)*

1.7 ± 0.5

1.9 ± 0.7

3.1 ± 1.4

< 0.05

Numbers in Italics are outside the desirable range

  1. DATA: MEAN ± SD
  2. * (In parenthesis: Desirable values)
  3. ** Analysis of Variance